BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 23068419)

  • 1. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease.
    Rajendra Kopalli S; Koppula S; Shin KY; Noh SJ; Jin Q; Hwang BY; Suh YH
    J Ethnopharmacol; 2012 Sep; 143(2):686-94. PubMed ID: 22902248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
    Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
    Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
    Carmo MR; Menezes AP; Nunes AC; Pliássova A; Rolo AP; Palmeira CM; Cunha RA; Canas PM; Andrade GM
    Neuropharmacology; 2014 Jun; 81():142-52. PubMed ID: 24508709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
    Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
    Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
    Oyagi A; Oida Y; Hara H; Izuta H; Shimazawa M; Matsunaga N; Adachi T; Hara H
    Brain Res; 2008 Jun; 1214():169-76. PubMed ID: 18457816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
    Chu JM; Chen LW; Chan YS; Yung KK
    Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
    Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
    Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
    Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
    Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
    Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
    Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells.
    Kwon SH; Ma SX; Hong SI; Kim SY; Lee SY; Jang CG
    J Ethnopharmacol; 2014 Feb; 152(1):173-82. PubMed ID: 24440915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
    Jalali-Nadoushan M; Roghani M
    Brain Res; 2013 Apr; 1505():68-74. PubMed ID: 23415934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.
    Chen HH; Lin SC; Chan MH
    Neurodegener Dis; 2011; 8(5):364-74. PubMed ID: 21494012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
    Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
    Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.